Insulin and IGF-I analogs: novel approaches to improved insulin pharmacokinetics.
Slieker
L J
LJ
Diabetes Research Division, Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, IN 46285.
Brooke
G S
GS
Chance
R E
RE
Fan
L
L
Hoffmann
J A
JA
Howey
D C
DC
Long
H B
HB
Mayer
J
J
Shields
J E
JE
Sundell
K L
KL
D000595:Amino Acid Sequence; D001667:Binding, Competitive; D005260:Female; D006801:Humans; D007328:Insulin / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism* / Q000493:pharmacokinetics; D007334:Insulin-Like Growth Factor I / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism* / Q000493:pharmacokinetics; D008969:Molecular Sequence Data; D010920:Placenta / Q000378:metabolism; D011247:Pregnancy; D017433:Protein Structure, Secondary; D017526:Receptor, IGF Type 1 / Q000378:metabolism; D011972:Receptor, Insulin / Q000378:metabolism; D011994:Recombinant Proteins / Q000378:metabolism; D013329:Structure-Activity Relationship
D007328:Insulin; D011994:Recombinant Proteins; D007334:Insulin-Like Growth Factor I; D017526:Receptor, IGF Type 1; D011972:Receptor, Insulin